SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Dec 12, 2017

AGENUS INC (AGEN) (CIK 0001098972)
Date: Dec. 12, 2017 · CIK: 0001098972 · Accession: 0001193125-17-367563

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-221465

Referenced dates: December 1, 2017

Date
December 12, 2017
Author
/s/ Zachary R. Blume
Form
CORRESP
Company
AGENUS INC (AGEN) (CIK 0001098972)

Letter

December 12, 2017

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention:

Mary Beth Breslin

Dorrie Yale

Re:

Agenus Inc.

Registration Statement on Form S-3, filed November 9, 2017

File No. 333-221465

Ladies and Gentlemen:

On behalf of Agenus Inc. (the “Company”), we submit via EDGAR this letter in response to the written comments of the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission, dated December 1, 2017 (the “Comment Letter”), with regard to the Company’s above-referenced Registration Statement on Form S-3 (the “Registration Statement”). For the convenience of the Staff’s review, we have set forth the comment contained in the Comment Letter in italics followed by the response of the Company.

General

1. We note that there is an outstanding comment on your 10-K for the fiscal year ended December 31, 2016 filed March 16, 2017, and on your Form 10-Q for the quarterly period ended September 30, 2017 filed on November 7, 2017. Please be advised that we will not be in a position to declare your registration statement effective until all comments on your Exchange Act filings are resolved.

Response:

The Company acknowledges the Staff’s comment that the Staff will not be in a position to declare the Company’s Registration Statement effective until all comments concerning the Company’s Exchange Act filings are resolved.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions or comments about this letter or need any further information, please call the undersigned at (617) 951-7663.

Very truly yours,
/s/ Zachary R. Blume

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 December 12, 2017

VIA EDGAR

 Securities and Exchange Commission

 Division of Corporation Finance

 100 F. Street, N.E.

Washington, D.C. 20549

Attention:

Mary Beth Breslin

Dorrie Yale

Re:

Agenus Inc.

Registration Statement on Form S-3, filed November 9, 2017

File No. 333-221465

 Ladies and Gentlemen:

 On behalf
of Agenus Inc. (the “Company”), we submit via EDGAR this letter in response to the written comments of the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission, dated
December 1, 2017 (the “Comment Letter”), with regard to the Company’s above-referenced Registration Statement on Form S-3 (the “Registration Statement”). For the
convenience of the Staff’s review, we have set forth the comment contained in the Comment Letter in italics followed by the response of the Company.

General

 1. We note that there is an
outstanding comment on your 10-K for the fiscal year ended December 31, 2016 filed March 16, 2017, and on your Form 10-Q for the quarterly period ended
September 30, 2017 filed on November 7, 2017. Please be advised that we will not be in a position to declare your registration statement effective until all comments on your Exchange Act filings are resolved.

Response:

 The Company acknowledges the Staff’s
comment that the Staff will not be in a position to declare the Company’s Registration Statement effective until all comments concerning the Company’s Exchange Act filings are resolved.

We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions or comments about this letter or need any further
information, please call the undersigned at (617) 951-7663.

 Very truly yours,

 /s/ Zachary R. Blume

Zachary R. Blume

cc:
Evan Kearns (Agenus Inc.)